Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...
Singapore: Prana Biotechnology announced the upcoming presentation of new data demonstrating the ability of PBT2 to redu...
Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology compan...
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...
Singapore: Department of Health and Ageing under the Australian Government's National Medicines Policy framework, is con...
Singapore: Australia's Minister for Technology, Mr Gordon Rich-Phillips launched the two-day Australia Biotech Invest 20...
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...
Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...
Singapore: Cellmid completed its first in-life diabetic nephropathy study with two of its anti-midkine antibodies (MK-Ab...
Singapore: Australia has acknowledged its bioscience innovators and companies through an industry excellence awards orga...
Singapore: Researchers have found a new variant of a gene that can confer five-fold protection against typhoid fever. Th...
Singapore: Medical device industry is a complex one and even more complex is the regulatory landscape of the sector, ech...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: Agilent Technologies has launched Spectroscopy Technology Innovation Center in Mulgrave, Australia, with an i...
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...
Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...
Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...
